Document Type : Original Article

Authors

1 Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Epidemiology and Biostatistics, School of public Health, Isfahan University of Medical Sciences, Isfahan, Iran

3 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

BACKGROUND: Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but severe condition that can develop in children who have had COVID-19. It can lead to cardiovascular complications, potentially caused by endothelial dysfunction and arterial stiffness.
METHODS: This study aimed to investigate the cardiovascular health of children with MIS-C compared to healthy controls. Fifty-nine children with MIS-C and fifty-nine healthy individuals were included in this cohort study. Non-invasive techniques were employed to measure the brachial artery’s flow-mediated dilation (FMD), aortic distensibility (AD), and aortic strain (AS).
RESULTS: The MIS-C group demonstrated significantly higher systolic blood pressure (P = 0.012), with a mean of 100.2 (10.1) mmHg compared to 95.3 (9.6) mmHg in the healthy group. The relative risk (RR) for elevated pulse pressure in the MIS-C group was borderline higher than in the healthy group (RR 95% CI: 1.06 [1.01–1.14]; P = 0.046). However, FMD, AS, and AD values were lower in the MIS-C group, with means of 13.6 (8.9), 10.4 (4.1), and 15.5 (2.7), respectively, although no significant differences were observed (P > 0.05).
CONCLUSION: Children with MIS-C exhibited higher pulse pressure, indicating potential arterial stiffness. They also showed lower FMD, suggesting endothelial dysfunction. FMD appears to be a more reliable indicator of endothelial dysfunction in MIS-C patients compared to aortic strain. These findings underscore the importance of early assessment and monitoring of cardiovascular complications in MIS-C patients. Endothelial dysfunction and arterial stiffness are well-established risk factors for future cardiovascular events.

Keywords

1. Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID-19: A multisystem disease? J Med Virol. 2021 Jan;93(1):323-35. https://doi.org/10.1002/jmv.26294
2. Navabi ZS, Ahmadi A, Sabri MR, Kholenjani FB, Ghaderian M, Dehghan B, Mahdavi C. Factors associated with preventive behaviors of COVID-19 among children with congenital heart disease: Application of protection motivation theory. J Educ Health Promot. 2022 Oct 31;11:332. https://doi.org/10.4103/jehp.jehp_1720_21
3. Sabri MR, Ahmadi A, Saviz M, Ghaderian M, Dehghan B, Mahdavi C, et al. Cardiac Function in Pediatric Patients with MIS-C Using Speckle Tracking and Conventional Echocardiography: A Longitudinal, Single-Center Study. Pediatr Cardiol. 2025 Feb;46(2):383-93. https://doi.org/10.1007/s00246-024-03432-w
4. Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021 Jul;180(7):2019-34. https://doi.org/10.1007/s00431-021-03993-5
5. Hejazi OI, Loke YH, Harahsheh AS. Short-term Cardiovascular Complications of Multi-system Inflammatory Syndrome in Children (MIS-C) in Adolescents and Children. Curr Pediatr Rep. 2021;9(4):93-103. https://doi.org/10.1007/s40124-021-00258-5
6. Çiftel M, Ataş N, Yılmaz O. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children. Eur J Pediatr. 2022 Jan;181(1):91-7. https://doi.org/10.1007/s00431-021-04136-6
7. Ahmadi A, Ghaderian M, Nourmohammadi H, Sabri MR, Dehghan B, Mahdavi C. Comparison of CIMT and FMD in the Brachial Artery between Children with Acyanotic Congenital Heart Disease and Healthy Controls: A Case-Control Study. J Tehran Heart Cent. 2023 Oct;18(4):256-60. https://doi.org/10.18502/jthc.v18i4.14824
8. Takei Y, Tomiyama H, Higashi Y, Yamashina A, Chikamori T. Association Between Endothelial Dysfunction and Left Ventricular Diastolic Stiffness - Subanalysis of the Flow-Mediated Dilation Japan (FMD-J) Study. Circ J. 2023 Aug 25;87(9):1203-11. https://doi.org/10.1253/circj.cj-22-0810
9. Bucci T, Parente R, De Feo G, Cardamone C, Triggiani M. Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis. J Allergy Clin Immunol. 2019 Oct;144(4):1106-11. https://doi.org/10.1016/j.jaci.2019.05.037
10. Sabri MR, Tavana EN, Ahmadi A, Mostafavy N. Does Vitamin C improve endothelial function in patients with Kawasaki disease? J Res Med Sci. 2015 Jan;20(1):32-6.
11. Seki M, Minami T. Kawasaki Disease: Pathology, Risks, and Management. Vasc Health Risk Manag. 2022 Jun 10;18:407-16. https://doi.org/10.2147/vhrm.s291762
12. Özdabakoğlu O, Güllülü S, Sağ S, Şentürk T, Kiliçarslan H, Tütüncü A, et al. Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil. Int J Impot Res. 2017 May;29(3):96-100. https://doi.org/10.1038/ijir.2016.47
13. Ciftel M, Turan O, Simşek A, Kardelen F, Akçurin G, Ertuğ H. Assessment of atrial electromechanical delay in children with acute rheumatic fever. Cardiol Young. 2014 Feb;24(1):27-32. https://doi.org/10.1017/s104795111200193x
14. Çiftel M, Ertuğ H, Parlak M, Akçurin G, Kardelen F. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction. Diab Vasc Dis Res. 2014 Jan;11(1):19-25. https://doi.org/10.1177/1479164113508564
15. Araújo CRDS, Fernandes J, Caetano DS, Barros AEVDR, de Souza JAF, Machado MDGR, et al. Endothelial function, arterial stiffness and heart rate variability of patients with cardiovascular diseases hospitalized due to COVID-19. Heart Lung. 2023 Mar-Apr;58:210-6. https://doi.org/10.1016/j.hrtlng.2022.12.016
16. Castelli R, Gidaro A, Casu G, Merella P, Profili NI, Donadoni M, et al. Aging of the Arterial System. Int J Mol Sci. 2023 Apr 7;24(8):6910. https://doi.org/10.3390/ijms24086910
17. Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021 Jan;17(1):46-64. https://doi.org/10.1038/s41581-020-00357-4
18. S Shakeel S, Ahmad Hassali MA. Post-COVID-19 Outbreak of Severe Kawasaki-like Multisystem Inflammatory Syndrome in Children. Malays J Med Sci. 2021 Feb;28(1):109-16. https://doi.org/10.21315/mjms2021.28.1.14
19. Bogatu LI, Turco S, Mischi M, Woerlee P, Bouwman A, Korsten EHHM, Muehlsteff J. A modelling framework for assessment of arterial compliance by fusion of oscillometry and pulse wave velocity information. Comput Methods Programs Biomed. 2020 Nov;196:105492. https://doi.org/10.1016/j.cmpb.2020.105492
20. Selvaraj S, Steg PG, Elbez Y, Sorbets E, Feldman LJ, Eagle KA, et al. Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry. J Am Coll Cardiol. 2016 Feb 2;67(4):392-403. https://doi.org/10.1016/j.jacc.2015.10.084
21. Thijssen DHJ, Bruno RM, van Mil ACCM, Holder SM, Faita F, Greyling A, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019 Aug 7;40(30):2534-47. https://doi.org/10.1093/eurheartj/ehz350
22. Romano M, Piskin D, Berard RA, Jackson BC, Acikel C, Carrero JJ, et al. Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis. Sci Rep. 2020 Oct 27;10(1):18374. https://doi.org/10.1038/s41598-020-75433-7
23. Mesquita Bastos J, Ferraz L, Pereira FG, Lopes S. Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension. Diagnostics (Basel). 2023 May 22;13(10):1817. https://doi.org/10.3390/diagnostics13101817